Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tycoon Group Holdings Limited ( (HK:3390) ) just unveiled an announcement.
Tycoon Group Holdings Limited reported a strong set of results for the year ended 31 December 2025, with revenue rising 25.2% year on year to HK$1,096.6 million as the group expanded sales of its healthcare and consumer products. Net profit more than doubled to HK$15.5 million, while EBITDA climbed to HK$64.0 million, reflecting improved operating efficiency and healthier margins despite higher selling and distribution expenses.
The company’s operating profit increased to HK$43.5 million, supported by a higher gross profit and a net reversal of impairment losses on financial assets, even as finance costs and losses from equity-accounted investments weighed on earnings. Although total comprehensive income surged to HK$16.1 million from HK$0.4 million a year earlier, the board opted to withhold a final dividend, signaling a focus on retaining capital to support ongoing operations and potential future growth initiatives.
The most recent analyst rating on (HK:3390) stock is a Hold with a HK$0.38 price target. To see the full list of analyst forecasts on Tycoon Group Holdings Limited stock, see the HK:3390 Stock Forecast page.
More about Tycoon Group Holdings Limited
Tycoon Group Holdings Limited is a Hong Kong-listed company operating in the consumer healthcare and wellness products sector. The group focuses on the distribution and retail of over-the-counter medicines, health supplements, personal care items, and related consumer products, primarily serving the Hong Kong and Greater China markets.
Average Trading Volume: 1,042,896
Technical Sentiment Signal: Sell
Current Market Cap: HK$228M
Find detailed analytics on 3390 stock on TipRanks’ Stock Analysis page.